Rauck RL - Search Results

1

Long-term safety of spinal cord stimulation systems in a prospective, global registry of patients with chronic pain.

Rauck RL, Loudermilk E, Thomson SJ, Paz-Solis JF, Bojrab L, Noles J, Vesper J, Atallah J, Roth D, Hegarty J, Prud'Homme M, Phillips GM, Smith SG, Ibrahim M, Willoughby CD, Obray JB, Gupta M, Paez J, Berg AP, Harrison NJ, Maino P, Mambalam P, McCarty M, Towlerton G, Love-Jones S, Ahmed S, Lee A, Shah B, Goor-Aryeh I, Russo MA, Varela N, Phelps JB, Cid J, Fernandez T, Pérez-Hernández C, Keehn D, Rosenow JM, Haider N, Parrent AG, Lawrence MM, Georgius P, Demartini L, Mendiola A, Mehta V, Thoma R, Israel AF, Carolis G, Bhatia S, Green M, Villarreal A, Crooks MT, Gwinn RP, Pilitsis JG, Sato H, Vega SM, Hillegass MG, Carnes P, Scherer C, Brill S, Yu J, Brennan JJ, Gatzinsky K, Navani A, Snook LT Jr, Bujedo BM, Andrés Ares J, Murillo A, Trobridge AT, Assil K, Shah J, McLeod C, Buwembo J, Coster O, Miller N, Sanapati M, Mikhael M, Przkora R, Sukenaga N, Raso LJ, Calodney AK, Cáceres Jerez LE, Uchiyama T, Kallewaard JW, Chandler B, Piedimonte F, Candido KD, Weaver TE, Agari T, Holthouse D, Woon R, Patel N, Lechleiter K, Jain R. Rauck RL, et al. Pain Manag. 2023 Feb;13(2):115-127. doi: 10.2217/pmt-2022-0091. Epub 2023 Jan 24. Pain Manag. 2023. PMID: 36691862 Free article.

2

Long-term safety of oral transmucosal fentanyl citrate for breakthrough cancer pain.

Payne R, Coluzzi P, Hart L, Simmonds M, Lyss A, Rauck R, Berris R, Busch MA, Nordbrook E, Loseth DB, Portenoy RK. Payne R, et al. J Pain Symptom Manage. 2001 Jul;22(1):575-83. doi: 10.1016/s0885-3924(01)00306-2. J Pain Symptom Manage. 2001. PMID: 11516599 Free article. Clinical Trial.

3

Long-term intrathecal opioid therapy with a patient-activated, implanted delivery system for the treatment of refractory cancer pain.

Rauck RL, Cherry D, Boyer MF, Kosek P, Dunn J, Alo K. Rauck RL, et al. J Pain. 2003 Oct;4(8):441-7. doi: 10.1067/s1526-5900(03)00730-2. J Pain. 2003. PMID: 14622664 Free article. Clinical Trial.

4

Relative analgesic potency of fentanyl and sufentanil during intermediate-term infusions in patients after long-term opioid treatment for chronic pain.

Reynolds L, Rauck R, Webster L, DuPen S, Heinze E, Portenoy R, Katz N, Charapata S, Wallace M, Fisher DM. Reynolds L, et al. Pain. 2004 Jul;110(1-2):182-8. doi: 10.1016/j.pain.2004.03.024. Pain. 2004. PMID: 15275766 Clinical Trial.

5

A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain.

Rauck RL, Wallace MS, Leong MS, Minehart M, Webster LR, Charapata SG, Abraham JE, Buffington DE, Ellis D, Kartzinel R; Ziconotide 301 Study Group. Rauck RL, et al. J Pain Symptom Manage. 2006 May;31(5):393-406. doi: 10.1016/j.jpainsymman.2005.10.003. J Pain Symptom Manage. 2006. PMID: 16716870 Free article. Clinical Trial.

6

Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: a 12-week, randomized, double-blind, placebo-controlled study.

Hale ME, Ahdieh H, Ma T, Rauck R; Oxymorphone ER Study Group 1. Hale ME, et al. J Pain. 2007 Feb;8(2):175-84. doi: 10.1016/j.jpain.2006.09.011. Epub 2006 Dec 4. J Pain. 2007. PMID: 17145204 Free article. Clinical Trial.

7

Titration with oxymorphone extended release to achieve effective long-term pain relief and improve tolerability in opioid-naive patients with moderate to severe pain.

Rauck R, Ma T, Kerwin R, Ahdieh H. Rauck R, et al. Pain Med. 2008 Oct;9(7):777-85. doi: 10.1111/j.1526-4637.2007.00390.x. Pain Med. 2008. PMID: 18950436 Clinical Trial.

8

Long-term safety, tolerability, and efficacy of OROS hydromorphone in patients with chronic pain.

Wallace M, Moulin DE, Rauck RL, Khanna S, Tudor IC, Skowronski R, Thipphawong J. Wallace M, et al. Among authors: rauck rl. J Opioid Manag. 2009 Mar-Apr;5(2):97-105. doi: 10.5055/jom.2009.0011. J Opioid Manag. 2009. PMID: 19507806 Clinical Trial.

9

Long-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic pain.

Simpson DM, Gazda S, Brown S, Webster LR, Lu SP, Tobias JK, Vanhove GF; NGX-4010 C118 Study Group. Simpson DM, et al. J Pain Symptom Manage. 2010 Jun;39(6):1053-64. doi: 10.1016/j.jpainsymman.2009.11.316. J Pain Symptom Manage. 2010. PMID: 20538187 Free article.

10

Once-daily gastroretentive gabapentin for postherpetic neuralgia: integrated efficacy, time to onset of pain relief and safety analyses of data from two phase 3, multicenter, randomized, double-blind, placebo-controlled studies.

Rauck RL, Irving GA, Wallace MS, Vanhove GF, Sweeney M. Rauck RL, et al. J Pain Symptom Manage. 2013 Aug;46(2):219-28. doi: 10.1016/j.jpainsymman.2012.07.011. Epub 2012 Nov 11. J Pain Symptom Manage. 2013. PMID: 23149085 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

156 results

Search Page